Skip to main content
. 2019 Jul 3;5(7):e02033. doi: 10.1016/j.heliyon.2019.e02033

Table 3.

Concentration of apolipoproteins (μg/dL) in the serum of patients with metabolic syndrome and patients without it (Me [Q1; Q3]).

Patients without MetS N = 27 Patients with MetS N = 26 p-value
ApoA1, μg/dL 55.23 [41; 73.75] 49.41 [37.12; 58.82] 0.266
ApoA2, μg/dL 37.9 [22.96; 60.51] 63.67 [32.6; 75.81] 0.017*
ApoC2, μg/dL 12.56 [7.22; 20.95] 32.4 [19.955; 49.06] <0.001*
ApoC3, μg/dL 24.035 [10.585; 44.34] 59.86 [39.205; 95.13] <0.001*
ApoE, μg/dL 4.36 [2.41; 5.33] 5.03 [4.05; 6.03] 0.075

Abbreviations: MetS – metabolic syndrome; ApoA1, ApoA2, ApoC2, ApoC3, ApoE – apolipoproteins A1, A2, C2, C3, E.Comparisons between groups were performed using Mann-Whitney U-test. * – p < 0.05 – statistically significant difference (highlighted in bold).